GFAP and alpha1a-AR staining and nuclear morphometry of oligodendrogliomas by confocal microscopy and image analysis: useful parameters for predicting survival in oligodendrogliomas by Moro-Rodríguez, Ernesto et al.
BioMed  Central
Page 1 of 4
(page number not for citation purposes)
Diagnostic Pathology
Open Access Proceedings
GFAP and alpha1a-AR staining and nuclear morphometry of 
oligodendrogliomas by confocal microscopy and image analysis: 
useful parameters for predicting survival in oligodendrogliomas
Ernesto Moro-Rodríguez*1, Javier Figols2, Mariano Alvira3, José A Uranga-
Ocio1 and Eduardo García-Poblete1
Address: 1Universidad Rey Juan Carlos, Faculty of Health Sciences. Av/Atenas s/n. E-28922 Madrid, Spain, 2Hospital Universitario Marqués de 
Valdecilla, Santander, Spain and 3Pathologist, LifeSpan BioSciences, Inc. Seattle, WA, USA
Email: Ernesto Moro-Rodríguez* - joseernesto.moro@urjc.es
* Corresponding author    
Abstract
Objective:  This study attempts to evaluate the GFAP and alpha1a-AR staining and
morphometrical nuclear features of oligodendrogliomas and their prognostic implications as
compared to present histopathology classification and their survival outcome.
Study design: Surgical specimens from 24 patients with oligodendrogliomas during the period
1981–2000 were included. These cases were classified into two groups defined by the grade of the
neoplasm: Group I: oligodendrogliomas grade II; Group II: oligodendrogliomas grade III and two
groups based on the outcome status: Group of the alive cases and group of the death cases. Death
rate for the groups were obtained by patients' charts. Descriptive statistics were used to examine
the groups with respect to the morphometrical nuclear variables; area, perimeter, aspect, axes
(major and minor), diameters (max, mean and min.), radius (max. and min.) margination, ratio of
perimeter-area, roundness and sizes (length and width). In addition, an immunofluorescence
method for GFAP and 1a-AR were performed and their area, density and intensity of staining were
analyzed.
Results: Semiautomated quantitative morphometrical results showed that the variables of nuclear
area (GII 48.87 μm2 vs. GIII 43.45 μm2 p-value = 0.02), aspect (GII 1.39 vs. GIII 1.55 p-value = 0.03),
axis minor (GII 6.66 μm vs. GIII 6.01 μm p-value = 0.003), diameter minor (GII 5.93 μm vs. GIII
5.27 μm p-value = 0.002), radius minor (GII 2.64 μm vs. GIII 2.25 μm p-value = 0,003), perimeter-
area (GII 0.0007 vs. GIII 0.0006 p-value = 0.04), size width (GII 6.60 μm vs. GIII 5.96 μm p-value =
0,003), and density of alpha1a-AR staining (GII 121.38 vs. GIII 146.03 p-value = 0.05) were
statistically significant in regard of grade; and that the sum of density of GFAP (p-value = 0.01) and
the intensity of alpha1a-AR (p-value = 0.01) were statistically significant in predicting survival.
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Conclusion: These results suggest that some nuclear morphometrical features and the GFAP and
alpha1a-AR immunofluorescence staining may be useful parameters for predicting survival in
oligodendrogliomas.
Introduction
Oligodendrogliomas (OD) are brain tumours predomi-
nantly composed of neoplastic oligodendroglial cells.
They occur mainly in patients 30–40 years old. They usu-
ally originate in the frontal lobe of the brain and these
patients usually present with chronic focal symptoms and
have a protracted clinical course. In other patients, OD
grows very quickly resulting in a fatal outcome. The WHO
classification grades OD into three groups: grades I and II
represent 90% of all OD and grade III include mixed oli-
godendroastocitomas and the malignant forms of OD [1].
However, most ODs are tumours with unpredictable out-
comes.
As previously has been reported by Nafe, the precise
description of the planar shapes of tumour cell nuclei by
light microscopy is of crucial relevance for the investiga-
tion of outcome in tumours because the pleomorphism of
nuclear shapes must be considered for typing, grading and
prognostic assessment of many tumour types [2].
Previous studies had shown a detailed nuclear shape anal-
ysis by means of Fourier analysis, and compared other size
and nuclear shape parameters with the measurement of
DNA index by DNA densitometry between different
tumour grades in oligodendrogliomas [2-4]. In order to
increase optimization of nuclear shape analysis in this
neuro-oncology study, we used here a fluorescent and
confocal methodology and a semiautomatic quantitative
analysis to improve the data obtained. The advantage of
these techniques is that it is possible to segment the
nucleus of each image in a more efficient way.
In the present study we performed two pairwise compari-
sons and tested the discriminatory power of different
nuclear shape characteristics for each of these compari-
sons: (1) Oligodendrogliomas WHO grade II vs. WHO
grade III; (2) comparison between the outcome survival
status (patients with oligodendrogliomas that survived
after five years vs. patients that died before five years) in
order to find significant prognostic features. In addition,
we used two antibodies to mark oligodendroglial and
astrocytic cells. A rabbit plyclonal antibody (379-LP1248)
against a unique peptide sequence of alpha1a-adrenocep-
tor (alpha1a-AR) and the glial fibrillary acid protein
(GFAP) were colocalized by confocal microscopy.
Student's paired and two tails t-test were used to compare
the mean values of the parameters studied.
Materials and methods
Twenty-four oligodendrogliomas+ and two relapses were
retrieved from the files of the Department of Pathology at
"Marques de Valdecilla Hospital", Santander (Spain),
over a period of more than ten years, beginning in 1981.
Formalin-fixed, paraffin-embedded tumour samples from
our files were employed. The tumours were characterized
according to age, sex, year of diagnosis and histological
degree in accordance with the WHO classification and
outcome. All tumours underwent routine histological
examination, including fixation in buffered formalin
(4%).
Immunofluorescence and immunohistochemical tech-
niques were used to co-localize the expression of 379-
LP1248 and GFAP (Ab1 – Glial Fibrillary Acidic Protein –
Bionova MS-280-R7). Propidium iodide was used for
counterstaining DNA. Antibody 379-LP1248, recognizing
a 16 amino acid peptide located in the third cytoplasm
loop of the alpha1a-AR, was purchased from Life Span
Biosciences, Seattle (WA).
Titration of antibody 379-LP1248 without antigen
retrieval was carried out. The best results were obtained at
1/750 – 1/1000 dilution. Against the 379-LP1854, a sec-
ondary antibody Alexa Fluor 488 goat anti rabbit
IgG(H+L) conjugated (Molecular Probes – Lab Net A-
11008) was used at 1/100 and Alexa Fluor 633 rabbit anti
mouse IgG(H+L) conjugated (Molecular Probes – Lab Net
A-21063) at 1/100. Propidium iodide was used for 5 min-
utes.
A light-microscopic immunohistochemical study in an
Axioplan/Axiophot 2 (Zeiss) was assessed semi-quantita-
tively by strength of staining (0 no stain, 1 weak, 2 mod-
erate, and 3 strong). In addition, a confocal
immunofluorescence quantitative study was performed in
a Laser Scanning Microscope LSM 510 META (Zeiss) with
a laser line of argon (458/488/514 nm 25 mW) and two
laser lines of helium-neon (543 nm 1 mW; 633 nm, 5
mW). For this second purpose, we captured images from
each case with three different optical magnifications,
objectives: ×20 plan-Apochromat numerical aperture
0.75; ×40 plan-Neofluor numerical aperture 1.3 oil and
×63 plan-Apochromat numerical aperture 1.4 oil. We got
an average of 7 pictures per case and a total number of 167
images for our statistical analysis. Between these images
we always carried out a tile scan of 3 × 3 or 4 × 4 with 20×
or 40× according to each case. From the 167 images col-Diagnostic Pathology 2008, 3:S26 http://www.diagnosticpathology.org/content/3/S1/S26
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lected, we recorded the mean, standard deviation and sum
of the fluorescent intensities, area and density of expres-
sion for each channel ignoring the intensities lower than
4%. Following this method, we got nine different numer-
ical values related to the immunoreactivity for the two pri-
mary antibody studied (GFAP and alpha1a-AR), and for
the propidium iodade.
Finally, nuclear area, perimeter, aspect, axes (major and
minor), diameters (max, mean and min.), radius (max.
and min.) margination, ratio of perimeter-area, round-
ness and sizes (length and width) were measured by
means of system for automated image analysis (Image Pro
Plus – Media Cybernetics) based on a single tiff picture
(512 × 512 pixels) per case at magnification ×400. In each
case around 150 and 300 nuclei from the most cellular
area were measured.
The statistical analysis was carried out using R software for
Linux. For the univariate statistical analysis, the t-test was
performed (two-sample t). A level of significance of p <
0.05 was adopted.
Results
In this study we have investigated 24 patients and 2 recur-
ring cases with clinical follow-up between three and seven
years respectively after the original diagnosis. The study
included 12 women and 12 men with ages ranging from
17 to 64 years (mean 37,69 F: 39,66 and M: 35,67). The
follow-up time of all the patients was over five years. Fif-
teen patients (62,5%) died (6 W and 9 M), including six
patients with recurring neoplasm. Only one patient died
before ten months after the diagnosis. Among the nine
surviving patients (6 W and 3 M), seven were free of dis-
ease (5 W and 2 M). Histological grade according to the
WHO classification included 14 cases with grade II and 10
cases with grade III.
The quantitative analysis showed that the mean value of
the nuclear area was 44.46 μm2; the mean nuclear perim-
eter value was 24.12 μm; the mean aspect value was 1.457;
the axes (major and minor) values were 9.040 μm and
6.415  μm respectively; the diameters (max, mean and
min.) values were 9.040 μm; 7.208 μm and 6.237 μm
respectively; the radius (max. and min.) values were 4.690
μm and 2.493 μm respectively; the margination value was
0.8610; the ratio of perimeter-area was 0.0007145; the
roundness value was 1.084 and the length and width sizes
values were 8.785 μm and 6.359 μm respectively.
No statistical differences were found when comparing the
nuclear parameters between the patients with oligoden-
drogliomas that survived to the tumour vs. patients whom
did not survive the tumour.
Antibody 379-LP1248 consistently stained interfascicular
and satellite oligodendrocytes in all human and guinea
pig samples studied. The staining was not limited to the
cell cytoplasm but, rather, it extended to thin branching
oligodendroglial processes involving the neuropil in gray
matter areas and myelinated fibers in the white matter.
Occasionally some fibrous astrocytes also appear to
faintly stain with antibody 379-LP1248, as confirmed by
confocal microscopy and colocalized with GFAP. The pre-
dominant stained cell population consisted of cells mor-
phologically identified as oligodendroglial in origin and
did not exhibit colocalization with GFAP.
Light microscopic immunohistochemistry showed for
alpha1a-AR a moderate staining of most cells in 12 (8
grade II/4 grade III) out of 26 OD tumours and strong
staining in 9 (6 grade II/3 grade III).
Unvaried inferential tests comparing the mean intensities
of fluorescence under LSM gives a mean of 566.07 for
379-LP1248, 243.62 for GFAP and 537.92 for IP with a t-
value of 24.150, 21.082 and 23.836 respectively. Pear-
son's correlation for bivariate relationships was significant
at 0.01 level for alpha1a-AR and GFAP.
The quantitative measurements of the immunofluores-
cence found significant differences comparing the mean
values of the groups of oligodendrogliomas grade II ver-
sus grade III by means of the alpha1a-AR density. In rela-
tion with the outcome survival status, the patients with
oligodendrogliomas that survived to the tumour had a
lower sum of GFAP density comparing with the no sur-
vival group (p < 0.05).
Discussion
Previous studies have shown that a detailed nuclear shape
analysis can detect morphological differences between
different tumour grades of brain tumours. In this way,
Fourier analysis provided an optimal statistical discrimi-
nation between data sets from proliferating and non-pro-
liferating tumour cell nuclei [2]. Other authors already
concluded that quantitative parameters concerning
nuclear size and shape could help to discriminate between
groups of patients with different survival periods even in
low-grade tumours [3]. Cytometry analysis found that the
mean nuclear area of patients with glioblastomas multi-
form, anaplastic gliomas and low-grade glioma was signif-
icantly larger in the SG2M phase cells than those on G0G1
phase cells [4]. In the present study we focused exclusively
on nuclear shape parameters comparing oligodendroglio-
mas based on their grade. Using a confocal microscopy
approach we have found that there are some nuclear vari-
ables as the area; aspect; axis, diameter and radius minor;
perimeter-area, size and width that were statistically sig-Publish with BioMed Central    and   every 
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nificantly related to the grade of the tumour. These find-
ings are of great value to avoid interobserver variability.
Using an antibody sensitive to a unique peptide sequence
of alpha1a-AR we have demonstrated immunolocaliza-
tion of this receptor in satellite and interfascicular oli-
godendrocytes in normal CNS tissue samples and in
neoplastic oligodendroglial cells in human oligodendrog-
liomas. Moreover, following a quantitative approach with
confocal microscopy, we showed that grade III OD exhib-
ited greater staining for alpha1a-AR receptors than grade
II OD. The non-specific staining with propidium iodade,
used as an internal control, validated our methodology.
In summary: 1) Semiquantitative morphometrical results
showed that the variables of nuclear area, aspect, axis
minor, diameter minor, radius minor, perimeter-area, and
size width were statistically significant in regard of OD
grade. 2) The patients with oligodendrogliomas that sur-
vived to the tumour had a lower sum of GFAP density
comparing with the no survival group. 3) We have shown
immunoreactivity to a novel antibody to alpha1a-AR in
oligodendrocites in normal SNC and in oligodendroglio-
mas. In addition and thanks to an immunofluorescence
quantitative approach, we have observed that grade III
OD exhibit greater presence of alpha1a-AR than grade II
OD.
These results suggest that certain nuclear morphometrical
features and the GFAP and alpha1a-AR immunofluores-
cence may be useful parameters in defining the nuclear
grade and survival outcome of OD.
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